Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates the page's revision was updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-05T11:15:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the study details page metadata. This reflects an internal revision rather than changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:05.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updates the Chile location listing to use shorter region labels (e.g., Araucania and Valparaiso) alongside the corresponding city/state entries, and updates the displayed site revision version.
    Difference
    0.4%
    Check dated 2026-04-24T05:44:21.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:17:38.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 as a study location and removed Padua, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T20:34:31.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The Italian trial site entry was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.
    Difference
    0.0%
    Check dated 2026-03-26T04:15:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.